ARWR vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 26, 2026

ARWR

61.6
AI Score
VS
PCRX Wins

PCRX

64.1
AI Score

Investment Advisor Scores

ARWR

62score
Recommendation
BUY

PCRX

64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ARWR PCRX Winner
Forward P/E 111.1111 8.1833 PCRX
PEG Ratio -1.32 11.2121 Tie
Revenue Growth -86.4% 5.0% PCRX
Earnings Growth 9.8% -30.0% ARWR
Tradestie Score 61.6/100 64.1/100 PCRX
Profit Margin -48.4% 0.7% PCRX
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.